Latest News
Biocentury
Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting.
Start-up obtains S1PR Modulator from Kyorin.
Press Release
Priothera Limited (priothera.com) has successfully closed a Series A financing round of up to €30 million led by Fountain Healthcare Partners with participation from co-lead investor HealthCap and funds managed by Tekla Capital Management, LLC as well as EarlyBird Venture Capital.
Contact Us
Priothera Ltd
88 Harcourt Street, Dublin 2, D02 DK18, Ireland
Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland
Priothera SAS France
9 Rue du Temple, Saint Louis, 68300, France
